menu
    • menu

    Company profile for Merus

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MerusNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Yalelaan 62, 3584 CM Utrecht
    Telephone
    Telephone
    +1 617 401 4499
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://merus.nl/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/merus/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MerusNV?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genmab Completes Tender Offer For Merus N.V. Shares
    Genmab Completes Tender Offer For Merus N.V. Shares

    12 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-12/genmab-announces-completion-of-tender-offer-for-outstanding-common-shares-of-merus-nv-and-commence

    PHARMIWEB
    12 Dec 2025
    Share Share
    Merus, Halozyme Sign Global Pact to Develop Petosemtamab
    Merus, Halozyme Sign Global Pact to Develop Petosemtamab

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/merus-and-halozyme-enter-global-collaboration-and-license-agreement-to-develop-subcutaneous-formulation-of-petosemtamab-302616859.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Merus’ Petosemtamab Shows Strong Activity in Metastatic CRC
    Merus’ Petosemtamab Shows Strong Activity in Metastatic CRC

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172890/37568/en/Merus-Interim-Data-on-Petosemtamab-in-Metastatic-Colorectal-Cancer-Demonstrates-Monotherapy-Activity-and-Robust-Response-Rate-in-Combination-with-FOLFOX-FOLFIRI-with-Well-Tolerated.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Genmab Initiates Tender Offer For Merus N.V. Shares
    Genmab Initiates Tender Offer For Merus N.V. Shares

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170170/0/en/Genmab-Commences-Tender-Offer-for-All-Issued-and-Outstanding-Common-Shares-of-Merus-N-V.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Merus Publishes Abstract on Petosemtamab in mCRC at AACR-NCI
    Merus Publishes Abstract on Petosemtamab in mCRC at AACR-NCI

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166055/37568/en/Merus-Announces-Publication-of-an-Abstract-on-Petosemtamab-in-Metastatic-Colorectal-Cancer-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeuti.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Merus To Present Petosemtamab Data In mCRC At AACR-NCI-EORTC
    Merus To Present Petosemtamab Data In mCRC At AACR-NCI-EORTC

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165684/37568/en/Merus-Announces-Petosemtamab-in-Metastatic-Colorectal-Cancer-Abstract-Selected-for-Plenary-Session-Oral-Presentation-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Tar.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search